HOW DOES COVID-19 AFFECT PEOPLE WITH EOE?
There are key COVID-19–related questions concerning eosinophils whose answers affect recommended prevention and care, says Marc Rothenberg, MD, PhD, Director of the Division of Allergy and Immunology.
Do patients with eosinophilia-associated diseases have an altered course of COVID-19? Do patients with eosinopenia (now intentionally induced by biological drugs) have unique COVID-19 susceptibility and/or disease course?
Read more in this publication appearing April 25, 2020, in the Journal of Allergy and Clinical Immunology: Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination
In addition to Rothenberg, Cincinnati Children’s co-authors were: Andrew Lindsley, MD, PhD, and Justin Schwartz, MD, PhD.
Stay tuned for more new EoE research, currently in preprint stages.